483
Adam M. Sun, M.DAdam M. Sun, M.D – FDA 483, Feb 25, 2022
Record Details
Adam M. Sun, M.D. in Rosemead, CA, was cited for significant deficiencies in clinical trial conduct during an FDA inspection. Observations included failures to conduct investigations according to protocol, delayed reporting of adverse events to the sponsor, inadequate investigational drug disposition records, and inaccurate case histories. These issues indicate a lack of adherence to regulatory requirements for clinical investigations.
View Company Profile
ID · ca6f7236-b607-4025-956f-fc3d9c44ad41
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.